(H4Z6) HSBC MSCI China USD EUR - Ratings and Ratios
Chinese, Stocks, Equity
Description: H4Z6 HSBC MSCI China USD EUR
The HSBC MSCI China UCITS ETF USD (Acc) EUR, traded on XETRA under the ticker symbol H4Z6, is an exchange-traded fund that tracks the Morningstar China TME NR USD Index. This ETF is designed to provide investors with exposure to the Chinese equity market, offering a diversified portfolio that mirrors the performance of its underlying index.
From a technical standpoint, the ETF has demonstrated a positive trend, with its short-term and long-term moving averages indicating a bullish outlook. The current price of 7.18 is above its 20-day, 50-day, and 200-day moving averages, suggesting a strong upward momentum. The Average True Range (ATR) of 0.10, equivalent to 1.34%, indicates a moderate level of volatility, which may present trading opportunities for investors.
Fundamentally, the ETF has a substantial Assets Under Management (AUM) of 1133.80M EUR, indicating a high level of investor confidence and liquidity. As the ETF tracks the Morningstar China TME NR USD Index, its performance is closely tied to the overall Chinese equity market. Given the current economic trends and the growth prospects of the Chinese market, this ETF may offer attractive investment opportunities.
Based on the technical and fundamental data, a forecast for the HSBC MSCI China UCITS ETF USD (Acc) EUR can be derived. Considering the bullish trend indicated by the moving averages and the moderate volatility, a potential price target for the ETF could be in the range of 7.50-8.00 in the short to medium term, representing a 4-11% increase from the current price. However, investors should be cautious of potential market fluctuations and adjust their strategies accordingly.
Additional Sources for H4Z6 ETF
H4Z6 ETF Overview
Market Cap in USD | 1,336m |
Category | China Equity |
IPO / Inception | 2022-07-12 |
H4Z6 ETF Ratings
Growth Rating | 20.1 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -4.37 |
Analysts | - |
Fair Price Momentum | 6.40 EUR |
Fair Price DCF | - |
H4Z6 Dividends
Currently no dividends paidH4Z6 Growth Ratios
Growth Correlation 3m | 42.4% |
Growth Correlation 12m | 70.9% |
Growth Correlation 5y | 24.9% |
CAGR 5y | 0.73% |
CAGR/Max DD 5y | 0.02 |
Sharpe Ratio 12m | 0.01 |
Alpha | 12.29 |
Beta | 0.552 |
Volatility | 21.38% |
Current Volume | 36.7k |
Average Volume 20d | 12.8k |
Stop Loss | 6.9 (-3.1%) |
As of July 09, 2025, the stock is trading at EUR 7.12 with a total of 36,746 shares traded.
Over the past week, the price has changed by +0.69%, over one month by -2.06%, over three months by +10.88% and over the past year by +24.68%.
Neither. Based on ValueRay´s Analyses, HSBC MSCI China USD EUR is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 20.08 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of H4Z6 is around 6.40 EUR . This means that H4Z6 is currently overvalued and has a potential downside of -10.11%.
HSBC MSCI China USD EUR has no consensus analysts rating.
According to our own proprietary Forecast Model, H4Z6 HSBC MSCI China USD EUR will be worth about 7.2 in July 2026. The stock is currently trading at 7.12. This means that the stock has a potential upside of +1.54%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 7.2 | 1.5% |